Eli Lilly: Big 2025 Ahead, But Execution Risks Exist
Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...
Business Insider23d
Eli Lilly ‘commends’ ITC ruling cracking down on unlawful tirzepatide imports
Eli Lilly (LLY ... federal law because their conduct was likely to deceive consumers about whether their imported ‘tirzepatide’ products were genuine Lilly medicines, and by falsely claiming ...